Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by stockman6767on Apr 11, 2018 10:48am
155 Views
Post# 27866088

RE:How the US MArket deals with Black Mamaba types and Shorters

RE:How the US MArket deals with Black Mamaba types and ShortersThat was pretty fast reaction by Vuzix. The defamatory articles were just published on March 16 & 20! If every defamed company reacted the same way and as quickly, there would be a lot less of this sort of scam and defamation going on. Now Pearson will be spending a lot of time and money defending himself from the $89M law suit!
Bullboard Posts